Former Chairman and CEO, CareFusion Corporation Age: 62 Director Since: 2015 Edwards Board Role: Audit Committee Member Other Current Public Company Directorships: Envista Holdings Corporation, since 2019 Chair of the Nominating and Governance Committee, since 2019 Other Public Company Directorships Previously Held: Arena Pharmaceuticals, Inc., from 2018 to 2022 Member of the Audit Committee, from 2018 to 2022 Intersect ENT, Inc., from 2015 to 2022 Chairman of the Board, from 2020 to 2022 Member of the Audit Committee, from 2015 to 2022 CareFusion Corporation, from 2011 to 2015 Volcano Corporation, from 2007 to 2015 ResMed Inc., from 2008 to 2011 Select Professional Experience and Highlights: CareFusion Corporation, a global medical technology company (acquired by Becton, Dickinson and Company in March 2015) Chairman and Chief Executive Officer, from 2011 until his retirement in 2015 ResMed Inc., a medical technology company focused on the treatment of sleep-related breathing disorders Chief Executive Officer, from 2008 to 2011 President, from 2004 to 2011 President and Chief Operating Officer, Americas, from 2003 to 2004 Nanogen Inc., a provider of molecular diagnostic tests Various positions, including President and Chief Financial Officer, from 1998 to 2002 Prior to 1998, various marketing, sales, and financial positions within Instrumentation Laboratory, a developer of laboratory hemostasis and critical care diagnostic testing solutions, the Procter & Gamble Company, a consumer goods manufacturer, and General Electric Company, a global infrastructure and technology conglomerate Served on the Board and Executive Committee, and as Chairman of the International Committee and Treasurer of Advanced Medical Technology Association (AdvaMed), an American medical device trade association Select Skills and Qualifications: Mr. Gallahue provides valuable insights and direction to our Board gained through extensive executive management experience at medical technology companies. His leadership roles on other public company boards and committees and prior experience as a public company chief financial officer also enable him to contribute informed financial and accounting perspectives to our Board and Audit Committee. Throughout his career, Mr. Gallahue has gained expertise and experience in areas that we believe are important to the success of our Company as we execute on our patient-focused innovation strategy, including experience in the medical technology industry, as a senior executive managing global operations, risk management and oversight, marketing and corporate strategy.